back to Directory

NonExomics

NonExomics logo

Founded
2021

Technologies

AI Companies (Drug Discovery)

NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – genomics, transcriptomics, proteomics – to predict nonexomic proteins and identify disease-causing targets. NonExomics partners with other biopharma organizations to design biomarker assays, identify biomarker candidates, therapeutic targets and drugs.


Posts Mentioning This Company

11 AI-powered Drug Discovery Startups Founded in 2021

  
The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several dozen companies with AI-fueled platforms were founded, and they successfully continued raising funding and establishing strategic collaborations to expand their pipelines and improve computational capabilities.  In this report, we summarize …